Phase II multicenter, randomized study to evaluate efficacy and safety of avelumab with gemcitabine/carboplatin (CG) vs CG alone in patients with unresectable or metastatic urothelial carcinoma (mUC) who are ineligible to receive cisplatin-based therapy
No Thumbnail Available
Identifiers
Date
2020-09-01
Authors
Perez Valderrama, B.
Castellano Gauna, D.
Pinto Marin, A.
Mellado Gonzalez, B.
Puente, J.
Climent Duran, M. A.
Domenech, M.
Vazquez Mazon, F. J.
Perez Gracia, J. L.
Bonfill, T.
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Elsevier
Metrics
Export
